DEA DEA and HHS Extend Telehealth Flexibilities for Controlled Substances Thomas Sullivan Jan 10, 2024 0 The Drug Enforcement Administration (DEA) and the HHS announced they will extend pandemic-era telehealth prescribing flexibilities…
FDA Comments Praise and Call for Clarification on FDA DAP Draft Guidance Thomas Sullivan Jan 10, 2024 0 The United States Food and Drug Administration (FDA) received more than 130 comments on its draft guidance on clinical diversity,…
